476 related articles for article (PubMed ID: 11923253)
1. Corneal pathogenesis of Staphylococcus aureus strain Newman.
Dajcs JJ; Austin MS; Sloop GD; Moreau JM; Hume EB; Thompson HW; McAleese FM; Foster TJ; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1109-15. PubMed ID: 11923253
[TBL] [Abstract][Full Text] [Related]
2. Effects of toxin production in a murine model of Staphylococcus aureus keratitis.
Girgis DO; Sloop GD; Reed JM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2064-70. PubMed ID: 15914624
[TBL] [Abstract][Full Text] [Related]
3. Corneal virulence of Staphylococcus aureus in an experimental model of keratitis.
Dajcs JJ; Thibodeaux BA; Girgis DO; O'Callaghan RJ
DNA Cell Biol; 2002; 21(5-6):375-82. PubMed ID: 12167239
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcus corneal virulence in a new topical model of infection.
Hume EB; Dajcs JJ; Moreau JM; Sloop GD; Willcox MD; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2904-8. PubMed ID: 11687535
[TBL] [Abstract][Full Text] [Related]
5. Age-related differences in rabbits during experimental Staphylococcus aureus keratitis.
O'Callaghan RJ; McCormick CC; Caballero AR; Marquart ME; Gatlin HP; Fratkin JD
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5125-31. PubMed ID: 17962465
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the role of gamma-toxin in experimental endophthalmitis using a hlg-deficient mutant of Staphylococcus aureus.
Supersac G; Piémont Y; Kubina M; Prévost G; Foster TJ
Microb Pathog; 1998 Apr; 24(4):241-51. PubMed ID: 9533895
[TBL] [Abstract][Full Text] [Related]
7. Reactions with Antisera and Pathological Effects of Staphylococcus aureus Gamma-Toxin in the Cornea.
Bierdeman MA; Torres AM; Caballero AR; Tang A; O'Callaghan RJ
Curr Eye Res; 2017 Aug; 42(8):1100-1107. PubMed ID: 28346009
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus aureus infection of the rabbit cornea following topical administration.
Tang A; Balzli CL; Caballero AR; McCormick CC; Taylor SD; O'Callaghan RJ
Curr Eye Res; 2012 Dec; 37(12):1075-83. PubMed ID: 22916736
[TBL] [Abstract][Full Text] [Related]
9. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
[TBL] [Abstract][Full Text] [Related]
10. Ocular virulence of capsule-deficient streptococcus pneumoniae in a rabbit keratitis model.
Reed JM; O'Callaghan RJ; Girgis DO; McCormick CC; Caballero AR; Marquart ME
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):604-8. PubMed ID: 15671288
[TBL] [Abstract][Full Text] [Related]
11. Acute inflammation of the eyelid and cornea in Staphylococcus keratitis in the rabbit.
Sloop GD; Moreau JM; Conerly LL; Dajcs JJ; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):385-91. PubMed ID: 9950597
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
13. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection.
O'Callaghan RJ; Callegan MC; Moreau JM; Green LC; Foster TJ; Hartford OM; Engel LS; Hill JM
Infect Immun; 1997 May; 65(5):1571-8. PubMed ID: 9125532
[TBL] [Abstract][Full Text] [Related]
14. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
[TBL] [Abstract][Full Text] [Related]
15. A highly virulent Staphylococcus aureus: rabbit anterior chamber infection, characterization, and genetic analysis.
Balzli CL; Bartell J; Dajcs JJ; McCormick CC; Caballero AR; Stroman D; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5114-20. PubMed ID: 20463315
[TBL] [Abstract][Full Text] [Related]
16. Accessory gene regulator controls Staphylococcus aureus virulence in endophthalmitis.
Booth MC; Atkuri RV; Nanda SK; Iandolo JJ; Gilmore MS
Invest Ophthalmol Vis Sci; 1995 Aug; 36(9):1828-36. PubMed ID: 7635657
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence.
Engel LS; Hill JM; Moreau JM; Green LC; Hobden JA; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):662-5. PubMed ID: 9501882
[TBL] [Abstract][Full Text] [Related]
18. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
Callegan MC; Hobden JA; Hill JM; Insler MS; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3017-23. PubMed ID: 1399405
[TBL] [Abstract][Full Text] [Related]
19. Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit.
Dajcs JJ; Thibodeaux BA; Girgis DO; Shaffer MD; Delvisco SM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3712-6. PubMed ID: 12454041
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ
Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
